Inno-Gene SA
WSE:IGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ambika Cotton Mills Ltd
NSE:AMBIKCO
|
IN |
|
C
|
Concord Acquisition II Corp
AMEX:CNDA
|
US |
|
Jiamei Food Packaging Chuzhou Co Ltd
SZSE:002969
|
CN |
|
A
|
Ador Welding Ltd
BSE:517041
|
IN |
|
Hammond Manufacturing Company Ltd
TSX:HMM.A
|
CA |
|
Kanzhun Ltd
HKEX:2076
|
CN |
|
Scorpio Tankers Inc
NYSE:STNG
|
MC |
Inno-Gene SA
EPS (Diluted)
Inno-Gene SA
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
I
|
Inno-Gene SA
WSE:IGN
|
EPS (Diluted)
zł0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-21%
|
|
|
N
|
Nanogroup SA
WSE:NNG
|
EPS (Diluted)
zł0
|
CAGR 3-Years
27%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
M
|
Medicofarma Biotech SA
WSE:MDB
|
EPS (Diluted)
zł0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
R
|
Ryvu Therapeutics SA
WSE:RVU
|
EPS (Diluted)
-zł4
|
CAGR 3-Years
1%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
S
|
Selvita SA
WSE:SLV
|
EPS (Diluted)
zł0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Inno-Gene SA
Glance View
Inno Gene SA engages in the management of startup biotechnology companies. The company is headquartered in Poznan, Woj. Wielkopolskie. The company went IPO on 2011-02-08. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.
See Also
What is Inno-Gene SA's EPS (Diluted)?
EPS (Diluted)
-1
PLN
Based on the financial report for Jun 30, 2024, Inno-Gene SA's EPS (Diluted) amounts to -1 PLN.
What is Inno-Gene SA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-21%
Over the last year, the EPS (Diluted) growth was -158%.
